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 Abstract 
Accurate characterization of extracellular vesicles (EVs) is critical to explore their diagnostic and therapeutic 
applications. As the EV research field has developed, so too have the techniques used to characterize them. 
The development of reference materials is required for the standardization of these techniques. This work, 
initiated from the ISEV 2017 Biomarker Workshop in Birmingham, UK, and with further discussion during the 
ISEV 2019 Standardization Workshop in Ghent, Belgium, sets out to elucidate which reference materials are 
required and which are currently available to standardize commonly used analysis platforms for characterizing 
EV size, concentration, refractive index, and epitope expression. Due to their predominant use, a particular focus 
is placed on the optical methods nanoparticle tracking analysis and flow cytometry.  
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 Introduction 
The connection of EVs to many aspects of human health and disease surged a global interest in the development 
of EV-based biomarkers and therapeutics [1]. The use of EVs requires techniques which are able to reliably 
characterize size distribution, concentration, and epitope expression, amongst others. EVs can be studied by 
ensemble and single particle techniques. An ensemble technique measures one or more properties of a bulk EV 
population e.g. enzyme-linked immunosorbent assay (ELISA), Western blot, total protein/lipid/nucleic acid 
concentration, or bead-based flow cytometry. Single particle techniques characterize EVs one-by-one. Examples 
of single particle techniques are flow cytometry, nanoparticle tracking analysis (NTA, a commercialized name of 
single particle tracking (SPT)), electron microscopy (EM) and resistive pulse sensing (RPS). Ensemble 
techniques are often scalable, sensitive, and therefore compliant with routine clinical applications. For example, 
the first widely used screening test for HIV was based on ELISA [2]. Despite these benefits, the use of ensemble 
techniques has only limited abilities to improve understanding of disease-specific EV subsets due to the 
component diversity of many body fluids. These often contain many different particles with overlapping size and 
physical properties, such as lipoprotein particles, protein complexes, small platelets and EVs from many cell 
types. When applied to putative disease-specific EV subsets, therefore, interpretation of ensemble techniques 
may rely heavily on the purity of the EV preparation. For example, a Western blot positive for an EV marker may 
be informative for a highly purified EV population, but not for a neat biological fluid, where the signal could come 
from soluble protein. In contrast, single particle techniques have the potential to identify single EVs and 
differentiate between EV subsets (EVs with common molecular profile or cargo) and other non-EV particles. If 
the technique is high-throughput and allows sufficiently multiplexed phenotypic characterization, it could even 
obviate the need for separation, a particularly important consideration for clinical applications..  
 
The detection of single EVs in body fluids is challenging because EVs (1) are heterogeneous in size, with the 
majority having a diameter <200 nm; (2) are also heterogeneous in composition, biogenesis and origin; (3) have 
a low (<1.42) refractive index (RI); and (4) often co-exist with non-EV components that overlap in biochemical 
composition and/or physical properties [3]. The diameter distribution of EVs in normal human plasma and urine 
have been shown to range between 50 nm to >1,000 nm [4, 5]. Because instruments detecting single EVs, such 
as flow cytometers, differ in sensitivity, and because only a fraction of the EVs exceeds the detection threshold, 
minute differences in the lower limit of detection will strongly affect the measured concentration of EVs [5]. 
Understanding the performance strengths and limitations of single EV characterization techniques is crucial to 
generate reliable and reproducible data and can also help to identify approaches to improve these analysis 
techniques and assays [6].  
 
There is a growing awareness that the reliability and reproducibility of EV measurements in general needs to 
improve. To become clinically relevant, EV measurements must be standardized. To this end, reference 
 materials and reference procedures require development. Rigor and standardization efforts in the field are 
represented by publication of “minimal requirements” (MISEV2014, MISEV2018) and improved recording of pre-
analytics in “EV-TRACK” [6-9], and also by standardization studies on EV concentration measurements by 
tunable RPS [10], flow cytometry [11, 12], NTA [13], and functional coagulation assays [14]. Recently, the ISEV-
ISAC-ISTH EV flow cytometry working group published a ‘minimum information for the reporting of an EV flow 
cytometry experiment’ (MIFlowCyt-EV) standard reporting framework, in an effort to increase the transparency 
and reproducibility of flow cytometry experiment protocols and reporting [15]. 
 
While the need for reference materials is becoming increasingly recognized, the nomenclature and purpose of 
reference materials within the EV field is currently poorly defined, with some nomenclature commonly misused. 
Here, we focus on understanding what is meant by a reference material, what types of reference material are 
required by the EV field, and how reference materials and EVs in general should ideally be characterized and 
reported. The majority of single EV measurements are currently performed using the optical characterization 
methods NTA  and flow cytometry [16]. We will therefore focus on standardization of these analysis methods, 
and draw several comparisons with non-optical measurement techniques. 
 
Assessing common EV characterization techniques 
A range of analysis techniques have been used to characterize EVs. Table 1 provides a comparison of popular 
EV analysis techniques, indicating their ability to provide measurements of diameter, immunophenotyping data, 
concentration, refractive index, single particle detection, detect all individual EVs, have a derivable sensitivity 
limit, and achieve a large sampling of particles (>10,000 events). As one of the first characteristics of an EV 
analysis technique is assessing whether it is detecting single or multiple (bulk) particles, techniques are split into 
these two respective cateogories.  
 
Diameter distribution determination Single particle methods are needed to generate accurate size 
distributions. For this reason, NTA, flow cytometry, and electron microscopy have been widely used for EV 
diameter distribution reporting [16]. Newer methods such as resistive pulse sensing, super-resolution 
microscopy, and interferometric reflectance imaging sensing (IRIS) are also beginning to be utilized [17, 18]. 
Bulk methods such as DLS that can be prone bias due to not measuring single particles are used increasingly 
less frequently.  
 
Molecular phenotyping. Bulk analysis techniques, such as Western blots, ELISAs, and bead capture assays, 
have been widely used and indeed instrumental in the field to date, associating EV phenotype (molecular cargo) 
with function. However, bulk analysis methods cannot convey if a particular analyte is in or on all EVs or just a 
subset, reveal the distribution of markers within a positive subset, or identify the size distribution or concentration 
 of the positive subset. They therefore lack the ability to characterize the heterogeneity of the EV population, 
which could be seen as critical for some of their intended uses in clinical chemistry. For this reason, there is a 
strong impetus to develop single particle analysis techniques, and an increasing number of platforms have 
become available. As seen in Table 1, only electron microscopy and super-resolution microscopy are capable 
of phenotyping single EVs of the smallest diameter. These are specialized and low-throughput (time-intensive) 
methods, though, that can analyze only a small portion of the population, possibly neglecting low abundance 
particles such as large EVs. High-throughput methods are therefore desirable for single particle phenotyping. 
NTA can technically be used for high-throughput fluorescence-based phenotyping, but low detection sensitivity 
and fluorophore bleaching have limited its application. Flow cytometry is another high-throughput possibility, but 
a lack of minimum procedural and reporting guidelines for single EV flow cytometry, combined with variable 
equipment sensitivities, settings, and staining methodologies, has led to a general lack of reproducible data. This 
has only recently been address in the form of the MIFlowCyt-EV framework [19].  
 
Concentration determination: The determination of concentration is a multifactorial measurement as it 
quantifies the amount of signal within a set volume. How well the measurement signal is being differentiated 
from background e.g. are all of the EVs detectable, and the ability to accurately determine the analysed volume 
both play a role in accurate concentration determination. If a technique is unable to detect all particles within a 
population, the correct interpretation of a particle concentration measurement therefore requires quantitation of 
the limit of detection of the measurement device. This then allows the reporting of concentration within a set 
sensitivity window i.e. 3x107 particles mL-1, limit of detection = 157 nm, that can be reproduced. 
 
The lower limit of detection (limit of sensitivity), is the threshold at which signal (such as light scatter for NTA) 
from a particle of given size can no longer be discriminated from the background. The limit of sensitivity can be 
described in numerous ways, with some easier to quantitate than others. In the above example with NTA, the 
limit of sensitivity could be reported in terms of the number of photons needed to resolve a signal from 
background, or as the diameter of a particle with a given refractive index. Despite this, it is also one of the few 
single-particle measurement techniques that also does not have a definable sensitivity limit with regard to light 
scatter intensity or fluorescence intensity in standard units. 
 
Sensitivity versus resolution. Distinguishing between ‘sensitivity’ and ‘resolution’ is important. While 
‘sensitivity’ describes the ability to detect a signal, ‘resolution’ describes the ability to distinguish one signal from 
another. Figure 1, depicts hypothetical results when three techniques are used to detect particles with diameters 
of 75, 100, and 125 nm: measured either as single populations (left column, Figure 1A, C, E) or when mixed 
together (right column, Figure 1B, D, F) to approximate a heterogeneous mixture of EVs. In this example, each 
particle population contributes an equal number of events. Although each technique is sufficiently sensitive to 
 detect the individual populations, resolution differs substantially. The method in Figure 1A, B has high resolution. 
Figure 1C, D shows a low-resolution method. The technique in Figure 1E, F loses resolution as particles (and 
their signal) become smaller. This latter pattern is typical of detection methods such as flow cytometry, NTA, and 
RPS. Clearly, our perception of a population size distribution can be skewed if resolution is not taken into account 
 
Current techniques: an overview. Each currently available platform for single EV characterization has 
strengths and weaknesses. NTA is widely used and can provide size, concentration, and even phenotyping data 
(when combined with affinity-linked fluorescence). However, it is unable to detect all EVs, and there is currently 
no published protocol to determine a lower limit of sensitivity in standard units for fluorescence or irrespective of 
refractive index for size. This is currently also true for the combination of IRIS (interferometry) and fluorescence. 
Resistive pulse sensing (RPS) is also incapable of detecting all individual EVs, as the pores used for the 
measurement have discrete size ranges. However, RPS can measure tens of thousands of events in a short 
period of time, and its measurement sensitivity can be deduced using currently available traceable size 
standards. Since RPS does not allow affinity-based phenotyping, EV size and concentration can be interpreted 
correctly only for populations well separated from potential co-isolates, such as lipoproteins in plasma. This is 
also the case for other techniques where affinity-based phenotyping is not or cannot be done. Currently, only 
single-EV flow cytometry combines abilities for sizing, concentration measurement, affinity-based phenotyping, 
and high throughput with calibration into standard units to provide a limit of sensitivity for each parameter. While 
not all techniques have a discernable limit of sensitivity that can be derived from a calibration and expressed in 
standard units, it is possible to perform indirect assessments of sensitivity using validation materials. It is also 
possible to track performance using quality controls. These are discussed in detail below. 
 
Background to reference materials 
Metrology is the science of measurement, fundamental to the definition of reference materials as it is the scientific 
study of measurements. Metrology is regulated by the International Bureau of Weights and Measurements 
(BIPM) and ensures international unification of physical measurements. The metrology field is established 
internationally with regards to nomenclature and regulatory agencies. The BIPM operates under the exclusive 
supervision of the International Committee for Weights and Measurements (CIPM), which established the 
International System of (SI) Units in 1960. The SI unit, known as the metric system, is the international 
measurement standard. The SI unit is recognized in nearly 50 countries, with the CIPM disseminating and 
modifying the definition of SI units as technology progresses. The International Organization for Standards (ISO) 
is an independent, non-government organization that interacts with BIPM. ISO is the largest developer of 
international standards and provides common standards between over 160 countries. Over 22,910 standards 
have been published to date. An example of an ISO standard is the definition of accuracy, ISO 5725-1:1994, 
‘Accuracy (trueness and precision) of measurement methods and results.’ National metrology institutes, such as 
 the US National Institutes for Standards and Technology (NIST), develop certified reference materials which are 
traceable to the SI unit using ISO standards. Measurement traceability is the property of a measurement result 
whereby the result can be related to a reference through a documented unbroken chain of calibrations, each 
contributing to the measurement uncertainty. 
 
The SI unit is made up of seven base units that define 22 derived units with special names and symbols, Figure 
2A. The use measurements of certified reference materials within laboratories can be traced back to the SI units, 
Figure 2B. An example is a gold size standard being made and characterized in comparison to an international 
size standard, Figure 2C. This gold size standard is used by manufacturers of polystyrene size standards which 
are characterized in relation to the gold size standard by electron microscopy. These polystyrene size standards 
can then be bought commercially and used to calibrate laboratory instrumentation. The working methods and 
reference materials with the laboratory instrumentation are then used to characterize assays output e.g. the size 
of an EV. As reference materials continue to be cross-calibrated, their accuracy and stability decreases, Figure 
2B. This is due to every measurement containing a certain amount of uncertainty and over increasing time and 
variable conditions stability decreases, Figure 3.  
 
‘Reference material’ is a generic term that refers to any material that is sufficiently homogeneous and stable with 
respect to one or more properties, and which has been established to be fit for its intended use in a measurement 
process [20]. A ‘certified reference material’ is characterized by a metrologically valid procedure for one or more 
of its properties and is accompanied by a certificate providing the values of the specified property, a statement 
of metrological traceability and associated uncertainty. Metrologically valid procedures for production and 
certification are outlines in ISO Guide 34 and 35, certificate contents ISO Guide 31. Reference materials can 
have different applications e.g. calibration, validation, quality control, etc. Each of these applications can require 
varying degrees of accuracy in their reference material characterization e.g. international standards, certified 
reference materials, working reference materials, and more. 
 
For a reference material to be traceable back to an SI unit, the uncertainty of a measurement must be known, 
Figure 3. The uncertainty of a measurement is the quantification of doubt about the measurement and is based 
upon the standard deviation and bias of a measurement. The standard deviation describes the precision of a 
measurement due to random error. The measurement bias describes the trueness of a measurement, which can 
be affected by systematic error. ‘Error’ in both systematic and random error describe the difference between the 
measured value and the ‘true value’ of the property being measured. The trueness and precision of a 
measurement, defined by ISO 5725, equate to the accuracy of a measurement, Figure 4. A measurement 
whereby the result is low in systematic error but high in random error is considered high in trueness but lacking 
in precision. A measurement whereby the result is high in systematic error but low in random error is considered 
 low in trueness but high in precision. Understanding these concepts is critical for the development of EV 
reference materials, assessing EV analysis equipment, and general investigation and characterization of EVs.  
 
Reference material categories for standardization of EV characterization techniques 
The development and utilization of reference materials may fall into one of the following categories: calibration, 
validation, and quality control. The need for certified vs uncertified reference materials for these needs will vary, 
as discussed below.  
 
Calibration is the conversion of an arbitrary unit scale to a scale in standard units. For example, converting the 
fluorescence intensity scale of a flow cytometer from arbitrary units to a scale of fluorophore number. Calibration 
requires well characterized reference particles. Ideally, the calibration reference materials would also be certified, 
so as to give a traceable measurement back to SI units and limiting the potential for bias in calibration accuracy. 
The development of certified calibration reference particles is crucial for instrument measurement calibration, 
instrument sensitivity quantification, and in turn instrumentation standardization and comparisons. Calibration 
reference material allow standardized reporting and consequently, validation of published EV studies between 
assays, instruments, and laboratories. The development of accurate calibration reference materials also allows 
the development of standardized quality control reference materials.  
 
Calibration reference materials do not necessarily need to mimic all characteristics of the downstream analysis 
particles, such as EVs. Materials such as polystyrene beads, hollow organosilica beads, liposomes, etc, could 
all be conceivably used as size standards, so long as the measurement technique sizing ability is based on 
physical size and not on other properties such as light scatter intensity (which would also depend on refractive 
index). Calibration reference materials for some parameters, such as fluorescence and light scatter, typically 
require a set of standards for multiple populations. Other parameters, such as concentration, can be based on a 
single calibration reference material.  
 
Validation assesses an assay’s sensitivity and specificity by using a known sample, such as a positive or 
negative control. For example, a scale could be calibrated to diameter units using a 100 nm certified diameter 
standard. To validate the calibration of the scale, a 150 nm certified diameter standard could be analyzed to 
check that the population appeared at 150 nm on the scale. An assay’s specificity for detecting CD41a-positive 
population could be validated by using a population of CD41a certified positive particles for a positive result. 
Inversely, the assay specificity for negative results could be validated using CD41a certified negative particles 
for a negative result. Validation reference materials appear to be the most sought-after within the EV field in 
order to test detection methods and assays. These types of reference materials can be used as positive and 
negative controls within assays by having previously characterized properties, such as protein expression, 
 concentration, diameter distribution, composition, etc. While in some cases calibration reference materials can 
also be used for assay validation, validation should not be carried out using the same reference material as used 
for calibration. Despite great potential for the use of EV reference materials for assay validation, currently only 
uncertified EV reference materials are commercially available. Uncertified reference materials can lack accuracy 
in characterization measurements, and depending on how they’re used for their downstream application can 
lead to bias in sample characterization e.g. using an incorrectly assigned size standard to calibrate a RPS device 
will lead to measurement inaccuracy of downstream sample diameter measurements. Many commercially 
available reference materials have not been rigorously quantified or otherwise characterized, and sometimes not 
at all. These types of reference materials are therefore not standard, and may not be traceable across different 
detection methods, and thus result in variable data across instrumentation. Their use as quality control reagents 
or assay development reagents on a single platform may, however, be useful.  
 
The development of certified EV reference materials is currently impeded due to limitations in sensitivity and 
resolution of commercially available analysis techniques. Most current commercially available techniques are 
not able to detect and/or phenotype the full range of the EV population as single particles or and/or cannot 
provide a large enough sampling of the population to produce robust measurements. Furthermore, many of the 
techniques that can provide a higher sampling of the EV population, as seen in Table 1, cannot yet be calibrated 
to provide a quantitative sensitivity limit or traceable measurement. The measurement bias of these techniques 
can therefore not be accounted for, and the “product specification” metrics provided along with reference 
materials will likely be inaccurate.  
 
Quality control assesses the performance of an assay (‘repeatability’ and ‘reproducibility’) to verify that it 
produces consistent results over time. Repeatability assesses whether a measurement is consistent when 
performed: at the same location; using the same measurement procedure; by the same observer; using the 
same measuring instrument, used under the same conditions; and repeated over a short period of time. 
‘Reproducibility’ assesses whether measurements are consistent when conducted by different individuals, at 
different locations, and with different instruments. Quality control can be assessed intra-assay with replicate 
samples or inter-assay with calibration or validation reference materials. Quality control for all measurement 
techniques is essential and is best quantified in standard units e.g. “the detection sensitivity decreased from 100 
nm to 150 nm.” 
 
Commercially available EV reference materials for standardization of EV analysis techniques 
A number of efforts are being undertaken to develop reference materials as EV mimetics for use as validation of 
assays and quality controls. Some come in the form of synthetic materials meant to mimic biological materials, 
such as hollow organosilica beads and liposomes, while others are derived from biological sources [21] [22-24]. 
 Synthetic materials such as hollow beads have the benefit of utilizing characteristics of EVs with fine control, 
such as low refractive indices and a core shell structure, whilst being in the format of a tightly defined population 
which will likely be unambiguous in its detectability using optical methods. Synthetic standards such as these 
are likely much easier to develop into certified reference materials due to being stable, homogeneous populations 
that are more amenable to analysis and assigning traceable metrics. However, hollow silica beads have not yet 
been developed to display or contain proteins or other molecules that would be useful as positive controls for 
assays and testing of reagents.  
 
Biological reference materials that have been proposed in the literature include virus particles, cell culture-
derived (including engineered) EVs, bacterial outer membrane vesicles, and biofluid-derived EVs (from urine, 
plasma, serum, etc.). Each of these biological reference material types has strengths and limitations that are 
application dependent. The generation of biological reference materials to a standard that allows certification is 
challenged by the large number of parameters involved and the lack of sensitive instrumentation that can provide 
traceable measurements. Perhaps the most achievable goal is that these EV reference materials be developed 
and reported in calibrated units that state the detection window of the reported metrics. Efforts to produce high-
quality biological reference materials with calibrated measurements are recent, and have been demonstrated in 
the form of retroviruses and recombinant EVs [23, 24].  
 
The development of assays, reagents, and detection methods strongly requires that biological reference 
materials are commercially available for assay validation. The lack of commercial availability is in part due to the 
lack of calibration and reporting standards within the field. The currently available reference materials that could 
be used for assay validation are shown in Table 2. Recently, an inter-societal flow cytometry working group with 
members from ISEV, ISAC, and ISTH made an effort to overcome the lack of experimental and reporting 
standards for flow cytometry. This effort resulted in the MIFlowCyt-EV reporting framework, which was published 
as a position paper in the Journal of Extracellular Vesicles, [19]. The majority of the MIFlowCyt-EV framework is 
applicable to most optical analysis techniques, despite being developed for flow cytometry. Utilization of the 
framework would result in a large step forward for the field, not only in standardizing reporting and being able to 
validate findings, but also in starting to characterize and create standard commercially available biological 
reference materials. 
 
A comparison of commercially available EV reference materials and the level to which they are characterized is 
collated into Table 2. The criteria from this table are metrics that we would propose as a bare minimum when 
considering the use of these materials for downstream characterization using an optical characterization method 
and reporting the results. These available reference materials include EVs, EV-sized retroviruses, and 
liposomes. An absolute minimum of reporting EV studies is describing the method used to separate the EVs [9]. 
 At this time, no commercial sources of biological reference materials in Table 2 provide proof of purity or 
indication of purification method. These reagents may, therefore, contain soluble proteins or free nucleic acids, 
that could have effects on downstream assays if used without further purification. The reporting of size 
distribution is a common and important factor when using reference materials for the characterization or 
validation of an assay using an optical analysis technique. While most studies report a diameter statistic, such 
as mean or median, few provide the variance of this diameter distribution, and no manufacturer currently provides 
the limit of sensitivity for the technique quantifying the diameter. As seen in Table 2, despite limitations in 
sensitivity quantification and standardization (Table 1), many of the diameter distributions of currently available 
biological EV mimetics utilise NTA. An approximate RI is reported for three reference materials, two of which are 
viral particles. Buoyant density was provided by only one manufacturer. Two manufactures provide known 
surface proteins and their brightness in calibrated units, while another with an extensive range of EV types gives 
no indication of known surface markers. Critically, no commercially available reference materials intended for 
use as EV references provide the limit of sensitivity for their measurement metrics.  
 
Development of new reference materials for standardization of frequently studied EV characteristics 
 
Refractive index determination 
The refractive index of a material determines how much light is scattered from it. The refractive index has no 
effect on measurements from non-optical techniques such as RPS. For optical techniques that detect light scatter 
(e.g. flow cytometry, NTA, DLS, NanoView), the refractive index strongly influences the particle measurements 
in the detectability of the particle or derivation of the particle diameter. The refractive index is therefore an 
important metric to be provided with a reference material if it is intended for use in optical analysis techniques. 
Current literature suggests that while the RI of EVs is lower than reference materials such as silica, it is variable, 
Figure 5. Indeed, the effective refractive index of vesicles will never be a single number due to a vesicle being 
a core-shell model, where the ratio of the shell (membrane) to the core (cytosolic portion) increases as EV size 
decreases. Smaller EVs will therefore have larger effective RIs than larger EVs, such that RI cannot be reported 
with a single metric.  
 
Calibration of optical analysis equipment for refractive index approximation generally requires utilizing particle 
scatter physics in the form of Mie theory. While refractometers exist, they tend to be designed for liquids or films 
and are therefore not optimized for single particles or polydisperse mixtures of spheres. The application of Mie 
theory modelling requires calibration with spherical particles of known diameter and refractive index in order to 
fit predicted scattering models to detection equipment [25-27]. Many certified polystyrene reference particles 
exist. These are monodisperse and have low variance and a reported refractive index. Unfortunately, few 
alternative materials are as well characterized. For some materials, such as silica, refractive index is assumed 
 based on published literature from measurements of silica films. These materials may thus be variable in 
composition quality, with few certified reference materials available. The refractive indices currently provided 
with certified reference particles tend to be reported to two decimal places and with no indication of variance; 
they are therefore not a traceable metric.  
 
Assay validation for sensitivity to detect particles of low refractive index remains difficult. Analyses of polystyrene 
particles were initially used to validate the sensitivity of optical analysis instrumentation. However, it was soon 
recognized that polystyrene, having a much higher refractive index, scatters far more light than most biological 
particles, and therefore is not an appropriate EV mimetic. Since then, focus has been directed to the use of silica 
particles, which, while lower in RI than polystyrene, still scatter more light than EVs. Liposomes have more 
recently been suggested as a better material for validating equipment sensitivity due to the similarity in RI to 
EVs; however, it is difficult to produce monodisperse liposomes with low variance at small diameters. Liposomes 
also tend to be multi-laminar if created using filters, thus increasing refractive index and not being representative 
of EVs with a single phospholipid bilayer. 
 
The ability to calibrate an instrument’s axis for refractive index will however continue to require the use of light 
scatter modelling and not be a traceable measurement until certified traceable refractive index reference particles 
exist. Without the ability to compare or validate refractive index measurements to a certified reference material, 
the accuracy of reported measurements will remain unknown.  
 
Epitope measurement 
Phenotyping, defined for our purposes here as classifying EVs by presence of surface markers, is a powerful 
tool in determining cell derivation and function of EVs. Methods to phenotype EVs vary from qualitative (e.g. 
Western blots), to semi-quantitative (e.g. ELISA, bead-capture assays, fluorescent NTA, EM), to quantitative 
(e.g. super-resolution microscopy, flow cytometry). Reference materials that display a known quantity of a 
particular epitope (i.e., target of an affinity reagent such as an antibody, peptide, or aptamer) will therefore be 
important for a wide variety of assays and analysis platforms.  
 
Crucial: limit of sensitivity. As for other types of measurements, it is critical to know the limit of sensitivity of 
phenotyping assays. To achieve a quantitative assay, this limit should be reported in standard units so that (for 
example) amount of bound fluorescent antibody can be expressed in molecules of equivalent soluble 
fluorophore. Reporting data in quantitative units (e.g. molecules of equivalent soluble fluorophore) instead of as 
relative expression or in arbitrary units (fluorescence intensity) allows for comparison of data across scientific 
institutions and platforms. Where this is impossible, many assays are still able to indicate the relative amount of 
an epitope, comparing single EVs or EV samples. In cases for which an epitope is undetectable, a lack of 
 detection should not be confused with proof that an epitope is truly absent from an EV. Instead, the result should 
be reported in context of the limit of sensitivity, along with other relevant variables of the particular assay. 
 
Fluorescence calibration. Development of reference materials for calibration of epitope abundance is 
contingent on the analysis technique. Currently, optical techniques are most widely used, relying predominantly 
on fluorescence for the quantification of phenotype, so fluorescence calibrators are required in the form of 
molecules of equivalent soluble fluorophore. These currently exist only in the form of uncertified reference beads 
in the range of 3-7 µm in diameter that lack traceability. The size and fluorescence of these beads reflects their 
originally intended use in cellular analyses and requires extrapolation of their values to be applicable to the 
majority of EVs (i.e. 10,000 MESF to <100 MESF). While the true fluorescence value (i.e. accuracy) of these 
brighter reference materials has not be validated for very dim particles, initial small particle calibration studies 
using these beads suggest that they are precise and produce concordant data irrespective of instrumentation 
[28-30]. This is entirely expected, as fluorescence scales linearly with the number of molecules present, and 
existing measurements can assess if a fluorescence detector scales linearly. The use of fluorescence calibration 
is highly recommended by the ISEV-ISAC-ISTH working group for flow cytometry, as outlined in the MIFlowCyt-
EV framework [19, 28].  
 
Size distribution 
The size (diameter, radius) of EVs is one of their defining characteristics. Current evidence suggests that EVs 
from some sources have a log-normal diameter distribution, Figure 6 [5]. That is, abundance scales inversely 
with size up to the peak of the distribution at a small size, which is itself determined by biophysical characteristics 
of lipid bilayer-delimited particles. Currently, no high-throughput analysis method is capable of sizing the full 
range of EVs (Table 1, [5]). A large limitation of the current literature is that reported EV diameters or diameter 
distributions do not state the limit of sensitivity of the detection equipment. For example, it is often stated that EV 
populations have a mean diameter of 100 nm. This is a distorted perception of the true EV size distribution, as 
in many cases the majority of EVs (small EVs) are undetectable and thus excluded from the distribution. A single 
metric to describe size distribution of EV samples—such as mean, mode, median, or percentile—is insufficient 
since it is biased by the sensitivity limit of the instrumentation, Figure 6. Techniques that rely on the composition 
of EVs (i.e., refractive index) for detection and inference of diameter, such as flow cytometry, NTA, DLS, and 
interferometry, will be biased by the refractive index of individual particles. Illuminate wavelength also contributes 
to sensitivity of optical techniques. An NTA instrument with a 405 nm laser will produce a slightly different size 
distribution compared with an instrument with a 640 nm laser due to the sensitivity of the instrument differing in 
light scatter from the particles at the two wavelengths. For these reasons, optical methods require calibration in 
order to determine their limit of sensitivity.  
 
 Flow cytometry: light scatter and fluorescence. The approximation of particle diameter from light scatter or 
fluorescence intensity in flow cytometry requires the use of light scatter calibration and fluorescence calibration, 
respectively [25, 27, 31]. Certified size standards are available for various sizes and compositions. These 
certified size standards are homogeneous and traceable in their diameter measurement, made from synthetic 
materials providing stability, and are often reported with a density and refractive index. Flow cytometer light 
scatter calibration can utilize certified diameter standards for the approximation of particle diameter. This 
measurement uses both the diameter of the certified reference particle and the non-traceable refractive index 
measurement. The accuracy of diameter approximated using flow cytometer light scatter is therefore multi-
factorial. Fluorescence calibration for EV size inference has been demonstrated with a liposome reference 
material of known diameter that is labelled with the same intercalating membrane dye as a population of EVs 
[31]. The fluorescence diameter measurement is also multifactorial and relies upon the accuracy of the liposome 
diameter, the detectability of the liposome population, and the fluorescence intensity of the liposome population 
as compared with the EV population. Importantly, both sizing methods allow for quantifying the limit of sensitivity 
in a standard unit of measurement irrespective of the instrument, allowing platform-independent comparisons.  
 
NTA: considerations and limitations. NTA sizes particles not by a single intensity measurement, as in flow 
cytometry, but rather by tracking the Brownian motion of particles over time (multiple measurements). Size is 
then inferred from the Stokes-Einstein equation. NTA does, however, rely on optical intensity to track particles 
over a sufficient length of time to derive an accurate size. Determining the limit of sensitivity for NTA would 
therefore require light scatter modelling or fluorescence calibration, depending on tracking mode, as well as 
some way to account for 1) the movement of particles in and out of the field of view, 2) changing intensities, and 
3) the ability of the instrument to track them. In light scatter mode, intensity depends on refractive index and 
illumination wavelength. The enumeration of particles is then affected by the camera’s varying noise, fluctuating 
at a pixel level over time, over which the software must identify and track a particle over several time frames. In 
fluorescence mode, additional information includes the amount of dye and rate of photobleaching. Currently, 
there is no demonstrated method to express limit of sensitivity for NTA in standard units, irrespective of factors 
such as refractive index of fluorescence intensity, such that comparisons could be made across instrumentation. 
 
In summary, certified reference materials for size measurements by platforms like flow cytometry and NTA do 
not actually rely, or solely rely, on the physical size of the reference material. Certified reference materials that 
cater to calibrated fluorescence measurements and refractive index are therefore required. Currently, certified 
sizing standards are most applicable to calibration of non-optical methods, such as RPS, allowing for statements 
about accuracy and limit of sensitivity. RPS is thus a useful orthogonal technique to assess optical sizing. 
Similarly, cryo-electron microscopy and similar techniques, despite being low- throughput, can be used to assess 
EV morphology across the full range of sizes and correlate findings between detection methods.  
  
The development of standard EV reference materials that can be used across optical techniques for validation 
of size distributions using light scatter requires knowledge of refractive index, which is not fixed across EV 
diameter and is not currently a traceable measurement using available methods. Similar standard reference 
materials for fluorescence requires knowledge of fluorescence intensity in standard units, which, while feasible, 
is not yet a traceable measurement and is currently only compatible with flow cytometers that are mostly unable 
to detect the whole EV population. A potential method of attempting to standardize optical size measurements 
is under investigation. A European standardization study (METVES II) attempts to make assay validators using 
hollow organosilica spheres of known sizethat mimic the core-shell structure of EVs, Table 2. This project aims 
to help standardize the field by using EV light scatter and fluorescence mimetics to validate instrument sensitivity.  
 
Concentration measurement 
Particle concentration may be a useful parameter to normalize EV input into an in vitro or in vivo assay, or even 
in the diagnostic setting. Despite being reported in almost every EV publication, EV concentration is one of the 
most difficult metrics to derive due to the systematic and random errors that are involved. No high-throughput 
analysis method is capable of detecting all EVs with a single configuration. Importantly, the limit of sensitivity for 
techniques such as flow cytometry, NTA, and RPS is generally not reported, even though this cutoff is crucial to 
knowing how many of the smallest and most abundant EVs are detected. The reported concentration of EVs is 
therefore likely one of the least accurate metrics in the literature. While certified reference materials for 
concentration measurements already exist, an accurate concentration measurement of a sample requires 
detection of all particles. This is not the case for techniques such as RPS, NTA, and flow cytometry. The solution 
to this problem is, however, relatively simple: reporting detectable events within a given detection window, using 
a calibrated instrument. If an instrument has been calibrated, a concentration can be reported within a given 
detection window e.g. “1.3x109 particles per mL were detected between 80-300 nm.”  
 
Calibrating EV analysis equipment to determine what can and cannot be detected in standard units is easier on 
some instruments than others. Instruments using RPS can be calibrated with size standards irrespective of 
optical characteristics such as refractive index. Optical techniques such as flow cytometry and NTA require light 
scatter calibration and/or fluorescence calibration to define their limits of sensitivity and their detection window. 
Both flow cytometry and NTA have a number of variables to account for, and well-defined, and ideally certified 
reference materials would be used for their calibration. These limitations are the same as those discussed 
previously for epitope measurement and size distribution. 
 
The development of EV reference materials with a known concentration is, therefore, heavily dependent on the 
instrumentation being used to quantify concentration and whether those instruments are capable of detecting 
 the whole population. When they are not capable of detecting the whole population, the concentration should be 
reported within a defined size range of the EV population. Given that current high-throughput methods are unable 
to detect the full EV population, it is unlikely that an accurate concentration measurement for the full EV 
population can be reported at this stage for current commercially available reference materials. If the limits of 
sensitivity are reported with reference materials, the concentration measurement can still, however, be 
normalized across instrumentation.   
 
Discussion 
The characterization of reliable EV reference materials requires the calibration of measurements obtained from 
any EV analysis technique. Calibration is also critical for the characterization of samples reported in published 
data. The utilization of current reference materials and development of new reference materials relies upon 
several factors. These include (a) continuing efforts in the EV field to develop educational resources and 
workshops for understanding and teaching the need and utilization of standardization procedures, (b) journals 
enforcing minimal criteria for reporting experiments using EV analysis techniques, and (c) encouraging industry 
to utilize and develop robust reference materials for calibration and quality control of EVs.  
 
The development of platform-independent reference materials is needed to facilitate cross-platform 
standardization. While flow cytometry and NTA were a particular focus of this piece, emerging optical techniques 
such as super-resolution microscopy and interferometry are also becoming more widely used. The 
standardization of these analysis techniques will be aided by the development of reference materials for flow 
cytometry and NTA, since each of these techniques measures optical signals.  
 
While the EV field currently and severely lacks standardization, this problem is recognized by the field. An 
example of an initiative aimed at development of traceable reference materials is METVES II, described in Text 
Box I. The International Society for Extracellular Vesicles (ISEV) in 2019 initiated a ‘Rigor and Standardization’ 
subcommittee to coordinate task forces across several pertinent areas, one of which is ‘EV Reference Materials’. 
Recently, an ISEV workshop, hosted in Ghent, Belgium was dedicated to Rigor and Standardization. Initiatives 
to standardize reporting have also been made in the form of MISEV, EV-TRACK, and MIFlowCyt-EV. Progress 
towards standardization is thus gaining momentum via concerted efforts. 
 
Textbox “METVES II (https://www.metves.eu), is a European metrology project in which metrology institutes, 
companies, and academia collaborate to achieve standardization of concentration measurements of EVs in 
clinical samples, such as plasma and urine [32]. METVES II focuses on standardization of EV concentration 
measurements by flow cytometry, since it is already available in hospitals and can characterize single EVs at 
high throughput (thousands/sec). All aspects of flow cytometry, including flow rate, fluorescence, and light scatter 
 (size, refractive index) need to be calibrated to produce reliable and reproducible results. Toward this goal, 
dedicated and traceable reference materials are being developed that combine physical properties resembling 
those of EVs. These materials will include stable particles with (i) diameters between 50 nm and 1,000 nm, (ii) 
concentrations in the range of 109 - 1012 particles mL-1, (iii) a visible fluorescence intensity between 100 and 
100,000 molecules of fluorophore, and (iv) a refractive index (RI) in the range of 1.37 – 1.42. Three types of 
reference materials will be developed: hollow organosilica beads (HOBs) [33], monodisperse liposomes, and 
low-RI solid particles. The size and concentration of the developed reference particles will be traceably 
characterized in SI units [34, 35]. It is hoped that this project will deliver a single reference material to calibrate 
all relevant properties involved in EV flow cytometry measurements.” 
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 Table 1 – Comparison of highly reported EV characterization methods. For diameter, immunophenotyping, 
concentration, and refractive index ticks depict whether the instrument provides or has been demonstrated to 
prove a particular measurement metric. For diameter, immunophenotyping, concentration, and refractive index, 
crosses indicate the instrument does not, is not able to, or has not been demonstrated in published literature to 
provide a particular element at the time of writing this review.  
 
Table 2 – Comparison of basic optical parameter characterization of commercially available reference 
materials. Information was collated using manufacturer websites and product sheets that were openly available. 
It is possible further is known about these products but that information is not freely/openly available at the time 
of writing this review.  
 
Figure 1 – The importance of resolution. A) demonstrated the detection of particles with a consistently high 
resolution (µ = 75, 100, 125 nm, ! = 3, 3, 3), B) shows the cumulative diameter distribution of particles from plot 
A. C) demonstrated the detection of particles with a consistently low resolution (µ = 75, 100, 125 nm, ! = 15, 15, 
15), D) shows the cumulative diameter distribution of particles from plot C. E) demonstrated the detection of 
particles with a typical detection technique resolution, whereby it decreases as the signal becomes smaller (µ = 
75, 100, 125 nm, ! = 15, 10, 3), F) shows the cumulative diameter distribution of particles from plot E. All 
populations have 10,000 particles. 
 
Figure 2 – Traceability to the SI unit. A) shows the seven base units of the SI unit, the outer circle shows the 
base unit measurement, the middle circle shows the measurement unit, the inner circle shows the measurement 
unit symbol. B) Hierarchy of traceability from the working methods and reference materials to the SI unit. C) 
shows an example of an EV measurement using RPS back to the SI unit. 
 
Figure 3 – Parameters involved in characterizing a certified reference material. 
 
Figure 4 – Visualizing the difference between trueness and precision. 
 
Figure 5 – Dispersion properties of polystyrene, silica and water from wavelengths of 400-800 nm. 
Dispersion properties of polystyrene, silica, and water were calculated using the Sellmeier equations for 
published materials [36-38]. Median refractive index (geometric mean in case of Gardiner et al) measurements 
for different EV sources were acquired from the literature [24, 26, 39-41]. 
 
Figure 6 – Limitations of statistical metrics on partially resolved populations. Shown is a hypothetical 
dataset with log-normal diameter distribution. Three limits of sensitivity (100 nm, blue; 150 nm, green; 300 nm, 
 red) are shown. The summary statistcs for events above these limits of sensitivity are shown in the corresponding 
colors in the right of the plot.
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